Market Research Logo

Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review

Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases. The company develops products based on a wide range of proprietary lung delivery technologies, including device and formulation capabilities. Vectura has a varied portfolio of drugs in clinical development, comprising several novel and generic programs that are partnered with several global biotechnology and pharmaceutical companies. Vectura is headquartered in Chippenham, Wiltshire, the UK.

Vectura Group Plc Key Recent Developments

Jun 01,2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director
Apr 20,2018: Vectura Announces Senior Management Change
Apr 20,2018: Vectura Group: Directorate Change - Chief Financial Officer
Mar 21,2018: Vectura Group: 2017 Preliminary Results
Mar 21,2018: Vectura Group: 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Vectura Group Plc - Key Facts
Vectura Group Plc - Key Employees
Vectura Group Plc - Key Employee Biographies
Vectura Group Plc - Major Products and Services
Vectura Group Plc - History
Vectura Group Plc - Company Statement
Vectura Group Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vectura Group Plc - Business Description
Vectura Group Plc - Corporate Strategy
Vectura Group Plc - SWOT Analysis
SWOT Analysis - Overview
Vectura Group Plc - Strengths
Vectura Group Plc - Weaknesses
Vectura Group Plc - Opportunities
Vectura Group Plc - Threats
Vectura Group Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Vectura Group Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 20, 2018: Vectura Group: Directorate Change - Chief Financial Officer
Mar 21, 2018: Vectura Group: 2017 Preliminary Results
Mar 21, 2018: Vectura Group: 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products
Nov 29, 2017: Vectura Group appoints Juliet Thompson to its Board of Directors
Oct 24, 2017: Vectura Group: Ultibro Breezhaler continues to deliver strong underlying growth in Q3
Sep 06, 2017: Vectura Group: 2017 Interim Results
Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016
Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016
Mar 06, 2017: Vectura Group: Board Change
Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Vectura Group Plc, Key Facts
Vectura Group Plc, Key Employees
Vectura Group Plc, Key Employee Biographies
Vectura Group Plc, Major Products and Services
Vectura Group Plc, History
Vectura Group Plc, Subsidiaries
Vectura Group Plc, Key Competitors
Vectura Group Plc, Ratios based on current share price
Vectura Group Plc, Annual Ratios
Vectura Group Plc, Annual Ratios (Cont...1)
Vectura Group Plc, Annual Ratios (Cont...2)
Vectura Group Plc, Interim Ratios
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Vectura Group Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Vectura Group Plc, Performance Chart (2013 - 2017)
Vectura Group Plc, Ratio Charts
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report